DePuy Synthes to open Bengaluru GCC, hire 500

DePuy Synthes, the orthopaedics division of Johnson & Johnson MedTech, will open a global capability center (GCC) in Bengaluru and recruit 500 professionals focused on software engineering, data analytics and artificial intelligence (AI). The new centre will act as a global hub for product innovation and technology development, consolidating engineering, cloud and R&D teams in a single offshore delivery location to support DePuy Synthes’ worldwide operations.

“India is one of the fastest-growing markets in the world for orthopaedic care, and this investment deepens our long-term commitment to patients, surgeons, and colleagues here,” said Namal Nawana, Worldwide President at DePuy Synthes.

The Bengaluru facility is being positioned to house cross-functional teams spanning software development, cloud engineering, data analytics and research and development. Hiring will prioritise talent with experience at the intersection of software engineering and healthcare applications, aligning with the centre’s remit to deliver digital innovation that supports clinical and operational outcomes for orthopaedic care.

Scope and strategic rationale

• Planned headcount: 500 hires across software, data and AI roles.
• Core functions: software development, cloud engineering, data analytics and R&D.
• Parent company: DePuy Synthes, part of Johnson & Johnson MedTech.

Company executives have framed the Bengaluru GCC as one of the largest commitments to an offshore innovation hub from a multinational medical device company in India. The move reflects a broader shift in enterprise outsourcing strategy, where owned GCCs are increasingly used to consolidate technology delivery and product innovation, complementing traditional third-party business process outsourcing relationships.

Industry observers point to India’s deep engineering talent pool and Bengaluru’s mature infrastructure for large-scale technology operations as key drivers for the site selection. The country’s GCC sector has continued to expand rapidly, with a reported addition of 510,000 jobs in the most recent reporting period — a metric that underlines the scale of offshore investment now concentrated in India’s technology corridors.

Operational focus and market implications

DePuy Synthes said the Bengaluru centre will prioritise roles that combine deep engineering expertise with healthcare domain knowledge, supporting the company’s digital agenda in orthopaedic care. By centralising product innovation and technology development within the Johnson & Johnson MedTech network, the company intends to accelerate development of software-enabled medical devices, cloud-native platforms and analytics that drive better clinical outcomes.

The commitment sends a clear signal that healthcare-linked technology functions are becoming as central to India’s offshore mix as traditional IT services. For multinational buyers evaluating delivery locations, the expansion of medtech GCCs into cities like Bengaluru increases competition for experienced engineering talent already being absorbed by record GCC hiring volumes.

As DePuy Synthes builds out the new centre, the company will compete in a market where multinational technology and life sciences firms regularly choose Bengaluru for large-scale engineering and R&D operations. The combination of specialised healthcare-domain roles and advanced software, data and AI capabilities positions the new GCC to play a strategic role in Johnson & Johnson MedTech’s global innovation footprint.